Dr. Paget was the Physician-in-Chief and Chairman of the Division of Rheumatology at Hospital For Special Surgery and the Joseph P. Routh Professor of Medicine and Rheumatic Disease at the Weill Medical College of Cornell University and the New York Presbyterian Hospital for fifteen years and is now the Physician-in-Chief Emeritus. As Chair, he developed and ran a world-class rheumatology division of 46 physicians, scientists and clinician-scholar educators who were focused on clinical, perioperative and consultative care throughout HSS and the York Avenue institutions, basic, translational and clinical and drug trials research and musculoskeletal education to medical students, residents and fellows.
During his time at the NIH and upon arriving at HSS in 1975, his basic immunologic research focused on defining the immunopathogenesis of rheumatoid arthritis. As an Associate Director of an NIH-funded Cornell Multipurpose Arthritis Center, he focused his clinical and translational research on the areas of steroid-induced osteoporosis, systemic vasculitides, rheumatoid arthritis, joint replacements and hip fractures. Most recently, Dr. Paget was a director of the Mary Kirkland Center for Lupus Research at HSS and on the Board of Directors of the Lupus Clinical Trials Consortium and his investigation was directed at attaining a broader understanding of premature atherosclerosis in autoimmune disorders.
He was a Member of the Board of Directors of the American Board of Internal Medicine and the Co-Chair of the rheumatology subspecialty Board. He has been a member of the Board of Directors of the Research and Education Foundation of the American College of Rheumatology and the Chair of its Development Advisory Council. He was recently honored by receiving the American College of Rheumatology’s Master designation and Distinguished Clinical Scholar award. He was a longstanding member of the Board of Trustees of the New York Arthritis Foundation.
Dr. Paget received his MD degree from Downstate Medical Center, did his residency in Internal Medicine at Johns Hopkins and was a Clinical Associate at the National Institute of Arthritis, Musculoskeletal and Skin diseases.
Dr. Paget has both national and international recognition as a Master Clinician in a broad range of inflammatory and autoimmune disorders. As a Clinician-Scholar Educator he has had a significant impact upon rheumatology education and is currently the Director of the HSS Rheumatology Academy of Medical Educators.
Physician-in-Chief Emeritus, Hospital for Special Surgery
Stephen A. Paget Rheumatology Leadership Chair
Systemic Lupus Erythematosus
Mixed Connective Tissue disease
Adult-onset Still's disease
Granulomatosis with polyangiitis (Wegener's Granulomatosis)
Churg Strauss Vasculitis
Giant Cell Arteritis/Polymyalgia Rheumatica
Arthritis associated with Crohn's disease and Ulcerative colitis
Reactive Arthritis/Reiter's syndrome
Osteoarthritis, general and spine
HSS Lifetime Achievement Award, 2010
Castle Connolly America's Top Doctors, 2002-2020
Castle Connolly Top Doctors in New York Metro Area, 2002-2020
New York Magazine Top Doctors, 2002, 2004-2007
Master of the American College of Rheumatology
Distinguished Clinical Scholar, American College of Rheumatology
Wholeness of Life Award
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Paget as of June 05, 2019.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
Creating an academy of medical educators: how and where to start. Berman JR, Aizer J, Bass AR, Cats-Baril WL, Parrish EJ, Robbins L, Salmon JE, Paget SA. HSS J. 2012 Jul;8(2):165-8. doi: 10.1007/s11420-012-9280-1. Epub 2012 Jun 19.
The role of imaging studies in today's rheumatology. Paget SA. Rheum Dis Clin North Am. 2013 Aug;39(3):xi-xiv. doi: 10.1016/j.rdc.2013.03.001. Epub 2013 Mar 15. No abstract available.
The microbiome, autoimmunity, and arthritis: cause and effect: an historical perspective. Paget SA. Trans Am Clin Climatol Assoc. 2012;123:257-66; discussion 266-7. No abstract available.
Building a rheumatology education academy: insights from assessment of needs during a rheumatology division retreat. Berman JR, Aizer J, Bass AR, Cats-Baril WL, Parrish EJ, Robbins L, Salmon JE, Paget SA. J Rheumatol. 2012 Jun;39(6):1280-6. doi: 10.3899/jrheum.111281. Epub 2012 Apr 15.
The risk of comorbidity. Peterson JC, Paget SA, Lachs MS, Reid MC, Charlson ME. Ann Rheum Dis. 2012 May;71(5):635-7. doi: 10.1136/annrheumdis-2011-200473. Epub 2012 Jan 18. No abstract available.
The New York City Rheumatology Objective Structured Clinical Examination: five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change. Berman JR, Lazaro D, Fields T, Bass AR, Weinstein E, Putterman C, Dwyer E, Krasnokutsky S, Paget SA, Pillinger MH. Arthritis Rheum. 2009 Dec 15;61(12):1686-93. doi: 10.1002/art.24738.
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, Crow MK, Sammaritano L, Levine DM, Salmon JE. Arthritis Rheum. 2009 Jan;60(1):22-9. doi: 10.1002/art.24148.
Five-year survival in a cohort of hip fracture patients: the predictive role of pre-fracture health status. Peterson MG, Cornell CN, Paget SA, Allegrante JP. HSS J. 2008 Feb;4(1):43-7. doi: 10.1007/s11420-007-9074-z. Epub 2007 Dec 13.
On the importance of early arthritis centers. Di Martino SJ, Paget SA. HSS J. 2005 Sep;1(1):107-9. doi: 10.1007/s11420-005-0119-x. No abstract available.
Prevalence of major life events among patients and community dwellers. Peterson MG, Allegrante JP, MacKenzie CR, Helfet D, Paget SA, Pangas M. HSS J. 2005 Sep;1(1):52-7. doi: 10.1007/s11420-005-0110-6.
Methodological challenges of multiple-component intervention: lessons learned from a randomized controlled trial of functional recovery after hip fracture. Allegrante JP, Peterson MG, Cornell CN, MacKenzie CR, Robbins L, Horton R, Ganz SB, Ruchlin HS, Russo PW, Paget SA, Charlson ME. HSS J. 2007 Feb;3(1):63-70. doi: 10.1007/s11420-006-9036-x.
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Roman MJ, Crow MK, Lockshin MD, Devereux RB, Paget SA, Sammaritano L, Levine DM, Davis A, Salmon JE. Arthritis Rheum. 2007 Oct;56(10):3412-9.
Systemic lupus erythematosus predicts increased left ventricular mass. Pieretti J, Roman MJ, Devereux RB, Lockshin MD, Crow MK, Paget SA, Schwartz JE, Sammaritano L, Levine DM, Salmon JE. Circulation. 2007 Jul 24;116(4):419-26. Epub 2007 Jul 9.
Guiding optimal therapy with the use of disease activity and functional instruments: lessons from the clinical laboratory. Paget SA. J Rheumatol Suppl. 2007 Jul;79:3-8.
Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Mancuso CA, Rincon M, Sayles W, Paget SA. Arthritis Rheum. 2007 May 15;57(4):672-8.
For more publications, please see the PubMed listing.
Clinical investigation into the pathogenesis and optimal treatment of rheumatoid arthritis, systemic lupus erythematosus, the systemic vasculitides, premature atherosclerosis associated with autoimmune disorders and steroid-induced osteoporosis.
Welcome to our practice. My staff and I are committed to providing you with the best possible rheumatology care anywhere in the setting of a warm, caring, supportive office environment that is aimed at improving the quality of your life. I will share my over 35 years of medical and rheumatology expertise with you, and we will both work toward developing a close partnership that will keep you as healthy as possible, no matter what your current state of health is.
My main aim is to be available for you for any problems that may arise. To this end, I will give you my email address at the end of your first visit because I believe that it is a superb way to communicate. However, for those of you who do not use email, you can contact me via telephone, facsimile, mail or in person.
Please be prepared for your appointment by completing the New Patient Forms (1-5 found below); we ask that you please bring them with you to the appointment filled out and completed. This preparation is necessary so that you can give me the best, most comprehensive, cumulative and up-to-date information about your overall health and your current rheumatologic problem. The better my appreciation of who you are, what your problem is, and how it has affected your life, the better I will be able to help you.
While most doctors are thorough in their discussions with you, it is always a good idea to come prepared for the appointment. You are encouraged to write questions specifically tailored to your concerns prior to arriving at your first appointment. The more in-depth the reporting of your questions, concerns and worries, the better we will be able to find the right answers and bring you back to full health. There is never too much information.
Because your time is as important as mine, we should both run on time. To help improve your experience, we try very hard to run our Practice on schedule. We are unable to do this if you are late. Help us to help you by arriving to your appointment with plenty of time to check in with the receptionist. A nurse will call for you once you’ve checked in to have your vital signs taken before bringing you in to meet with Dr. Paget.
Needed medical records should be requested 7-10 business days prior to the needed date.
Please call the office directly at 212.606.1845 to make an appointment and register. New patient appointments are one hour long and booked in advance. Follow-up visits usually last 15-20 minutes or longer if necessary. Our phone lines are answered by an answering-service from 12:00 – 1:00 p.m. Kindly leave a detailed message and the call will be returned.
If you are unable to attend your appointment which you have booked, please call and cancel within 24 hours so that the appointment can be offered to someone else. Persistent failure to attend the appointments that are booked and excessively cancelled will lead us to consider whether we can continue to reschedule your appointment.
Ms. Monica Lighty – Office Manager